AFP and hepatocellular carcinoma: The results of our meta-analysis suggested that AFP+GP73 is superior to AFP alone in diagnosing HCC and differentiating HCC patients from non-HCC patients, therefore, it might be a useful compound marker in the diagnosis and screening of potential HCC patients.